BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19483128)

  • 1. Factors associated with completion of the human papillomavirus vaccine series.
    Neubrand TP; Breitkopf CR; Rupp R; Breitkopf D; Rosenthal SL
    Clin Pediatr (Phila); 2009 Nov; 48(9):966-9. PubMed ID: 19483128
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
    Cook RL; Zhang J; Mullins J; Kauf T; Brumback B; Steingraber H; Mallison C
    J Adolesc Health; 2010 Dec; 47(6):596-9. PubMed ID: 21094437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF; Freed GL
    J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
    [No Abstract]   [Full Text] [Related]  

  • 4. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 5. Who should get the HPV vaccine?
    Pichichero ME
    J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
    Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
    Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
    Guerry SL; De Rosa CJ; Markowitz LE; Walker S; Liddon N; Kerndt PR; Gottlieb SL
    Vaccine; 2011 Mar; 29(12):2235-41. PubMed ID: 21288799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccine recommendations.
    Committee on Infectious Diseases
    Pediatrics; 2012 Mar; 129(3):602-5. PubMed ID: 22371460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009.
    Dorell CG; Stokley S; Yankey D; Markowitz LE
    Vaccine; 2012 Jan; 30(3):503-5. PubMed ID: 22119587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic.
    Kouyoumdjian FG; Bailowitz A
    Pediatr Infect Dis J; 2011 Aug; 30(8):718-9. PubMed ID: 21343841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches.
    Rouzier R; Giordanella JP
    J Adolesc Health; 2010 Sep; 47(3):237-41. PubMed ID: 20708561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
    Boot HJ; Wallenburg I; de Melker HE; Mangen MJ; Gerritsen AA; van der Maas NA; Berkhof J; Meijer CJ; Kimman TG
    Vaccine; 2007 Aug; 25(33):6245-56. PubMed ID: 17630049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
    Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
    [No Abstract]   [Full Text] [Related]  

  • 16. Quadrivalent human papillomavirus vaccine initiation, coverage, and compliance among U.S. active component service women, 2006-2011.
    Maktabi H; Ludwig SL; Eick-Cost A; Yerubandi UD; Gaydos JC
    MSMR; 2012 May; 19(5):16. PubMed ID: 22694590
    [No Abstract]   [Full Text] [Related]  

  • 17. Early lessons learned from extramural school programs that offer HPV vaccine.
    Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT
    J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catch up program for human papillomavirus vaccine.
    Weisberg E
    Aust Fam Physician; 2008 Dec; 37(12):983. PubMed ID: 19149027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.